Cyberknife Archives - Page 8 of 8

10 YEARS OF DATA SHOWS CYBERKNIFE PROVIDES EXCELLENT LONG-TERM CONTROL OF PROSTATE CANCER

by Prostate Cancer Center | Jan 2, 2018 | Prostate Cancer

Accuray Incorporated (NASDAQ: ARAY) announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent had local disease control 10 years after receiving stereotactic body radiation therapy (SBRT) administered with the...

Next Entries »

10 YEARS OF DATA SHOWS CYBERKNIFE PROVIDES EXCELLENT LONG-TERM CONTROL OF PROSTATE CANCER

Recent Posts

Recent Comments

Links

Resources

Contact